1. Home
  2. NRDY vs FATE Comparison

NRDY vs FATE Comparison

Compare NRDY & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nerdy Inc.

NRDY

Nerdy Inc.

N/A

Current Price

$10.33

Market Cap

114.0M

Sector

Technology

ML Signal

N/A

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

N/A

Current Price

$2.55

Market Cap

125.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NRDY
FATE
Founded
2007
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
125.6M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
NRDY
FATE
Price
$10.33
$2.55
Analyst Decision
Hold
Buy
Analyst Count
1
6
Target Price
$1.00
$4.10
AVG Volume (30 Days)
421.5K
1.7M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
13.16
29.88
EPS
N/A
N/A
Revenue
N/A
$6,646,000.00
Revenue This Year
$4.88
N/A
Revenue Next Year
$10.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.93
52 Week High
$11.03
$3.23

Technical Indicators

Market Signals
Indicator
NRDY
FATE
Relative Strength Index (RSI) 92.92 47.44
Support Level $0.83 $1.01
Resistance Level N/A $2.88
Average True Range (ATR) 0.29 0.18
MACD 1.12 -0.02
Stochastic Oscillator 92.44 40.00

Price Performance

Historical Comparison
NRDY
FATE

About NRDY Nerdy Inc.

Nerdy Inc operate a next-generation live tutoring and intervention platform that leverages the power of human expertise with Developed artificial intelligence (AI) to personalize learning, accelerate student achievement, and empower educators. The company's proprietary platform leverages technology, including AI, to connect learners with instructors across a wide range of subjects and formats, including subscription-based learning, one-on-one instruction, small group tutoring, large-format classes, and assessments. Its flagship business operates under the Varsity Tutors brand. The company's offerings are available directly to students and consumers, as well as through schools and other institutions.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: